AlivaMab Discovery Services (ADS) Announces Agreement with Tanabe Research Laboratories USA
ADS announces integrated antibody drug discovery collaboration
SAN DIEGO, Calif. – June 3, 2020 – AlivaMab Discovery Services, LLC, a leader in comprehensive, integrated solutions for antibody drug discovery, announced a discovery partnership with Tanabe Research Laboratories USA, Inc. (TRL, San Diego, California), an independent subsidiary of Japan-based Mitsubishi Tanabe Pharma Corporation. ADS will provide its expertise and capabilities to generate and deliver therapeutic antibody candidates to TRL using the AlivaMab® Mouse, a best-in-class antibody discovery platform.
"The proven expertise of ADS combined with the speed and efficiency with which AlivaMab Mouse can produce drug-quality antibodies is foundational for this collaboration” said John “Lippy” Lippincott, PhD, Vice-President of Research. “ADS has developed a track record of successfully delivering antibody drug candidates against challenging projects in a greater number and in shorter timelines than other organizations. We are pleased that TRL has entrusted ADS as a partner in using precision science to create breakthrough biological therapies.”
About AlivaMab Discovery Services (ADS)
AlivaMab Discovery Services is dedicated to our partners' successes in the discovery and development of human therapeutic antibodies. ADS’ fully-integrated therapeutic antibody discovery platform leverages the team’s expertise built on cumulative decades of experience in building and using antibody drug discovery platforms and processes, which includes the execution of over 200 discovery projects that has yielded several dozen antibody drug candidates in clinical trials, and seven approved antibody drugs. Our drug discovery experience crosses diverse therapeutic areas including oncology, autoimmune and inflammatory disease, metabolic, ocular, and infectious disease.
AlivaMab Discovery Services uses the AlivaMab Mouse of Ablexis, LLC to deliver panels of high affinity therapeutic antibody candidates, with extensive molecular and epitope diversities, functional and kinetic characterization, with unmatched speed. With the broad and deep expertise of the ADS team, we develop innovative solutions for immunizations, antibody recovery, antibody screening, and functional assay development and execution for even the most difficult project to give clients of ADS a distinct advantage for their antibody drug discovery projects.
About Tanabe Research Laboratories (TRL)
TRL is an independent subsidiary of Mitsubishi Tanabe Pharma Corporation located in San Diego California, whose role is to discover and develop biological drug candidates for therapy. Currently, TRL's efforts are directed towards antibody and antibody-related research to target tumors and other diseases with high unmet needs.